Ranked by reported Q1 2026 13F market value
Share of total reported institutional value in KYTX held by the largest 10 / 25 filers.
| # | Institution | Shares Held | Market Value | QoQ Change | Ownership % | % of Fund |
|---|---|---|---|---|---|---|
| 1 | GordonMD Global Investments LP | 4.2M | $36.6M | -3.4% | 9.693% | 25.51% |
| 2 | GILEAD SCIENCES, INC. | 4.1M | $35.6M | 0.0% | 9.422% | 1.68% |
| 3 | Bain Capital Life Sciences Investors, LLC | 3.1M | $26.8M | 0.0% | 7.102% | 2.42% |
| 4 | AIGH Capital Management LLC | 2.0M | $17.3M | +33.3% | 4.567% | 3.53% |
| 5 | DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2.0M | $17.3M | 0.0% | 4.567% | 0.20% |
| 6 | VANGUARD CAPITAL MANAGEMENT LLC | 1.8M | $15.4M | — | 4.072% | 0.00% |
| 7 | BALYASNY ASSET MANAGEMENT LLC | 1.1M | $9.7M | +14.7% | 2.570% | 0.03% |
| 8 | MILLENNIUM MANAGEMENT LLC | 1.0M | $8.7M | +69.5% | 2.296% | 0.01% |
| 9 | Insight Holdings Group, LLC | 989K | $8.5M | 0.0% | 2.259% | 0.60% |
| 10 | MORGAN STANLEY | 977K | $8.4M | -2.5% | 2.232% | 0.00% |
| 11 | BlackRock, Inc. | 877K | $7.6M | +61.1% | 2.003% | 0.00% |
| 12 | Woodline Partners LP | 845K | $7.3M | +0.0% | 1.930% | 0.03% |
| 13 | D. E. Shaw & Co., Inc. | 722K | $6.2M | +39.2% | 1.648% | 0.01% |
| 14 | Propel Bio Management, LLC | 644K | $5.6M | -3.3% | 1.472% | 3.52% |
| 15 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 633K | $5.5M | +117.2% | 1.446% | 0.00% |
| 16 | MBB PUBLIC MARKETS I LLC | 614K | $5.3M | 0.0% | 1.403% | 0.76% |
| 17 | MARSHALL WACE, LLP | 606K | $5.2M | +346.5% | 1.383% | 0.01% |
| 18 | ADAGE CAPITAL PARTNERS GP, L.L.C. | 500K | $4.3M | -70.0% | 1.142% | 0.01% |
| 19 | UBS Group AG | 450K | $3.9M | +122.4% | 1.027% | 0.00% |
| 20 | GEODE CAPITAL MANAGEMENT, LLC | 424K | $3.7M | +59.1% | 0.968% | 0.00% |
| 21 | BNP PARIBAS ARBITRAGE, SA | 412K | $3.6M | +63.4% | 0.941% | 0.00% |
| 22 | RENAISSANCE TECHNOLOGIES LLC | 367K | $3.2M | +106.6% | 0.839% | 0.00% |
| 23 | Qube Research & Technologies Ltd | 334K | $2.9M | +424.5% | 0.762% | 0.00% |
| 24 | VANGUARD FIDUCIARY TRUST CO | 225K | $1.9M | — | 0.513% | 0.00% |
| 25 | Point72 Asset Management, L.P. | 223K | $1.9M | +592.7% | 0.509% | 0.00% |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). “% of Fund” shows how much of that investor’s total 13F portfolio is invested in KYTX — a direct measure of their conviction.
Filings activity in KYTX during Q1 2026, grouped by how each filer changed its position.
8 quarters of 13F filings · Δ columns show change vs prior quarter
| Quarter | Inst. Holders | Δ Holders | Ownership % | Δ Ownership | Total 13F Value | Δ Value |
|---|---|---|---|---|---|---|
| Q1 2026 | 108 | +8.0% | 81.30% | 5.47 pp | $287M | 6.3% |
| Q4 2025 | 100 | +35% | 86.77% | +50.67 pp | $306M | +140% |
| Q3 2025 | 74 | 5.1% | 36.10% | +17.83 pp | $127M | +98% |
| Q2 2025 | 78 | 9.3% | 18.27% | +4.81 pp | $64M | +36% |
| Q1 2025 | 86 | 1.1% | 13.46% | 16.26 pp | $47M | 55% |
| Q4 2024 | 87 | 6.5% | 29.72% | 8.21 pp | $105M | 22% |
| Q3 2024 | 93 | +5.7% | 37.93% | 27.87 pp | $134M | 42% |
| Q2 2024 | 88 | — | 65.80% | — | $232M | — |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Δ columns compare to the immediately prior filed quarter.
Quick answers to the most common questions about buying KYTX stock.
Based on Q1 2026 13F filings, institutional ownership of Kyverna Therapeutics, Inc. stands at 81.3%, held across 108 reporting institutions.
GordonMD Global Investments LP is the largest reported institutional holder of KYTX, with approximately 4,244,818 shares worth $0.04B as of Q1 2026.
Yes — 4 widely-followed marquee investors appear among the top 25 institutional holders of KYTX, including MILLENNIUM MANAGEMENT LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, RENAISSANCE TECHNOLOGIES LLC, Point72 Asset Management, L.P..
Our composite Smart Money Score for KYTX is 54 out of 100 (Neutral). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.
26 institutions opened new positions in KYTX during Q1 2026, while 18 fully exited. 27 added to existing positions and 55 trimmed.
KYTX institutional ownership fell by 5.47 percentage points quarter-over-quarter, with a net change of +8 holders.
The top 10 institutions account for 64.3% of all reported 13F value in KYTX, and the top 25 account for 88.0%.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.
Kyverna Therapeutics, Inc. (KYTX) Institutional Ownership